Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure

Marios ArvanitisDepartment of Medicine, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA; View further author information

Gloria G. ChanAmyloidosis Center, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA; View further author information

Daniel R. JacobsonDepartment of Medicine, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA; ;Amyloidosis Center, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA; ;Section of Hematology/Oncology, Medical Service, VA Boston Healthcare System, Boston, MA, USA; View further author information

John L. BerkDepartment of Medicine, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA; ;Amyloidosis Center, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA;

http://orcid.org/0000-0002-1768-2373 View further author information

Lawreen H. ConnorsAmyloidosis Center, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA; ;Department of Pathology and Laboratory Medicine, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA;

http://orcid.org/0000-0002-4672-4296 View further author information

Frederick L. RubergAmyloidosis Center, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA; ;Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine/Boston Medical Center, Boston, MA, USACorrespondence[email protected]

http://orcid.org/0000-0002-6424-4413 View further author information

References

Jacobson DR, Alexander AA, Tagoe C, et al. Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans. Amyloid. 2015;22:171–174.
PubMed Web of Science ®Google Scholar
Quarta CC, Buxbaum JN, Shah AM, et al. The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015;372:21–29.
PubMed Web of Science ®Google Scholar
Arvanitis M, Koch CM, Chan GG, et al. Identification of transthyretin cardiac amyloidosis using serum retinol-binding protein 4 and a clinical prediction model. JAMA Cardiol. 2017;2:305–313.
PubMed Web of Science ®Google Scholar
Gillmore JD, Maurer MS, Falk RH, et al. Non-biopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–2412.
PubMed Web of Science ®Google Scholar
Dungu JN, Papadopoulou SA, Wykes K, et al. Afro-Caribbean heart failure in the United Kingdom: cause, outcomes, and ATTR V122I cardiac amyloidosis. Circ Heart Fail. 2016;9:e003352.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date